UniQure: Accelerated Approval Plan With US FDA May Save Five Years

Gene Therapy AMT-130 Could Become First Huntington’s Therapy

 
• By Joseph Haas
  
Amsterdam-based uniQure is looking for accelerated approval in Huntington's disease (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from R&D